Account
Wieden + Kennedy, Publicis win Visa’s global creative accounts
NEW DELHI: Visa has handed over its creative accounts worth $200 million to Wieden + Kennedy and Publicis Groupe. While Wieden + Kennedy will now be responsible for leading its creative strategy and major initiatives, Publicis Groupe will be in charge of production duties.
Publicis Groupe’s Saatchi & Saatchi, which handles the brand’s advertising in Europe, will continue to work with Visa as part of the new arrangement. Visa will also continue to work with Starcom, which has been associated with the brand since 2015.
The decision was taken after a review that was kicked off by Visa earlier in June. Incumbent agency BBDO, which was handling the account since 2012, was also invited to participate in the review.
Visa CMO Lynne Biggar said, "As one of the top five most valuable global brands, we are excited by the work ahead and thrilled to have these two amazing agencies delivering on best-in-class creative for Visa."
He also thanked BBDO for "its long-standing partnership with Visa over the past many years."
Wieden + Kennedy global co-president & CCO Colleen DeCourcy said, "In Wieden + Kennedy offices worldwide, feet haven't touched the ground since we heard the news. It's an honour that a trusted brand like Visa would place its trust in us."
Publicis Groupe global president and CEO UK – creative practice Magnus Djaba said, "It’s a huge honour for us to take on this additional scope to partner with Visa and Wieden+Kennedy in creating this new model, which I’m confident will deliver transformational growth for Visa around the world. We’re looking forward to expanding our relationship with Visa as we become the global partner across creative operations, media and production.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
